News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Earnings
Cryo-Cell International (CCEL) Reports Financial Results For Fiscal 2014 3/4/2015
Amicus Therapeutics, Inc. (FOLD) Announces Full-Year 2014 Financial Results And Corporate Updates 3/4/2015
Receptos (RCPT) Provides Development Updates And Reports Fourth Quarter And Year End 2014 Financial Results 3/4/2015
Adamas Pharmaceuticals (ADMS) Reports Fiscal 2014 Financial Results 3/4/2015
MacroGenics, Inc. (MGNX) Provides Update On Corporate Progress And 2014 Financial Results 3/4/2015
Codexis, Inc. (CDXS) Reports 2014 Fourth Quarter And Full Year Results 3/4/2015
Aptose Biosciences Reports Results For The Quarter And Seven Months Ended December 31, 2014 3/4/2015
VWR Corporation Reports Strong Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
IMRIS Reports Fourth Quarter And Annual 2014 Financial Results 3/4/2015
Conatus Pharmaceuticals Inc. To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Reports Fourth Quarter And Full Year 2014 Financial Results And Corporate Update 3/4/2015
AcelRx Pharmaceuticals (ACRX) To Hold Annual 2014 Financial Results Conference Call And Webcast On Monday, March 9th, 2015 3/4/2015
Imprimis Pharmaceuticals (immy) To Host Its Fourth Quarter And Fiscal Year 2014 Financial Report Conference Call And Webcast On March 12, 2015 At 4:30 P.M. EDT 3/4/2015
Webcast Alert: Heska Corporation (HSKA) Announces Fourth Quarter And Year End 2014 Earnings Conference Call Webcast 3/4/2015
Geron Corporation (GERN) Reports Fourth Quarter And Annual 2014 Financial Results And Recent Events 3/4/2015
Veeva Systems, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results 3/4/2015
Ocular Therapeutix, Inc. (OCUL) To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
GTx, Inc. (GTXI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015
ArQule, Inc. (ARQL) Reports Fiscal 2014 Year End And Fourth Quarter Results 3/4/2015
Theravance Biopharma To Report Fourth Quarter 2014 Financial Results On March 10, 2015 3/4/2015
Akebia Therapeutics, Inc. (AKBA) Announces Fourth Quarter And Full-Year 2014 Financial Results 3/4/2015
Eleven Biotherapeutics (EBIO) Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015
Newron Pharmaceuticals (NWRN) Reports 2014 Financial Results 3/4/2015
Derma Sciences, Inc. (DSCI) To Hold Fourth Quarter Financial Results Conference Call On March 12th 3/4/2015
Bellicum (BLCM) To Report Fourth Quarter And Full Year 2014 Financial Results On March 11, 2015 3/4/2015
IGI Laboratories, Inc. Announces Fourth Quarter And Year End 2014 Results 3/3/2015
Clinigen Group Plc Release: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m 3/3/2015
DURECT Corporation (DRRX) Announces Fourth Quarter 2014 Financial Results And Update Of Programs 3/3/2015
TONIX Pharmaceuticals, Inc. (TNXP) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
NeoStem, Inc. Announces 2014 Year-End Financial Results And Provides Corporate Update 3/3/2015
Intrexon Corporation Announces Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Ocera Therapeutics, Inc. (OCRX) To Announce Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
ReVance Therapeutics, Inc. (RVNC) Releases Fourth Quarter And Full Year 2014 Financial Results And Reiterates 2015 Outlook 3/3/2015
Mylan Inc. (MYL) Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% To $1.05 And Full Year Adjusted Diluted EPS Up 23% To $3.56 3/3/2015
Zogenix, Inc. (ZGNX) Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Oncothyreon Inc. (ONTY) Announces Full Year And Fourth Quarter 2014 Financial Results Conference Call 3/3/2015
Kindred Bio (KIN) To Announce Fourth Quarter And Year-End 2014 Financial Results 3/3/2015
OncoMed Pharmaceuticals, Inc. (OMED) To Report Full Year And Fourth Quarter 2014 Financial Results On Thursday, March 12, 2015 3/3/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Announces 2014 Operating Results 3/3/2015
Halozyme Therapeutics, Inc. (HALO) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Rigel (RIGL) Announces Fourth Quarter And Year End 2014 Financial Results 3/3/2015
INSYS Therapeutics Reports Fourth Quarter And Year End 2014 Results 3/3/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Fourth Quarter And Year End 2014 Financial And Operational Results 3/3/2015
Puma Biotechnology (PBYI) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Ipsen (IPN.PA)’s 2014 Results and 2015 Financial Objectives 3/3/2015
Clinigen Group Plc: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m 3/3/2015
Chimerix (CMRX) To Announce Fourth Quarter And Year End 2014 Financial Results On March 6, 2015 3/2/2015
Intercept Pharmaceuticals (ICPT) Announces 2014 Financial Results 3/2/2015
Portola Pharmaceuticals, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results And Provides Corporate Update 3/2/2015
Second Quarter Results - Fiscal 2015 - Ergoresearch Inc. (ERG) Reports Its Results For The Quarter Ended December 31, 2014 3/2/2015
Asterias BiotherapeuticsTo Report Fourth Quarter And Full Year 2014 Results On March 10, 2015 3/2/2015
BioScrip (BIOS) Reports Fourth Quarter 2014 Financial Results 3/2/2015
Endo International (ENDP) Reports Fourth Quarter And Full Year 2014 Financial Results 3/2/2015
Lexicon Pharmaceuticals, Inc. (LXRX) To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 3/2/2015
Endocyte, Inc. (ECYT) Reports Fourth Quarter And Year End 2014 Financial Results And Provides Clinical Updat 3/2/2015
ImmunoCellular Therapeutics, Ltd (IMUC) To Report 2014 Financial Results On March 9, 2015; A Business Update Conference Call And Webcast Is Scheduled For March 12, 2015 3/2/2015
Allergy Therapeutics plc Release: Interim Report For The Six Months Ended 31 December 2014 3/2/2015
Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results 3/2/2015
BIND Therapeutics (BIND) To Report Fourth Quarter And Year-End 2014 Financial Results On March 11, 2015 3/2/2015
PharMerica Reports Fourth Quarter And Full Year 2014 Results 3/2/2015
Getinge Annual Report 2014 3/2/2015
Antibe Therapeutics Inc. (ATE.V) Reports Q3 2015 Interim Financial And Operating Results And Director Resignation 3/2/2015
Horizon Pharma plc.  (HZNP) Announces Fourth Quarter And Full Year 2014 Financial Results And Raises Guidance For 2015 3/2/2015
ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3/2/2015
Synageva BioPharma (GEVA) Reports 2014 Full Year Financial Results 2/27/2015
IRIDEX Corporation (IRIX) Announces Fourth Quarter And Full Year 2014 Conference Call And Release Date 2/27/2015
Rockwell Medical (RMTI) Reports Fourth Quarter 2014 Results 2/27/2015
Raptor Pharmaceutical Inc. (RPTP) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides 2015 Corporate Update 2/27/2015
Hyperion Therapeutics (HPTX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
TetraPhase Pharmaceuticals (TTPH) To Host Conference Call Discussing Fourth Quarter And Full-Year 2014 Financial Results And Recent Highlights 2/27/2015
BioScrip (BIOS) To Host Fourth Quarter And Year-End 2014 Earnings Call 2/27/2015
Inogen (INGN) To Announce Fourth Quarter And Full Year 2014 Results On Thursday, March 12, 2015 2/27/2015
Novavax, Inc. (NVAX) Reports Fourth Quarter And Year-End 2014 Financial Results 2/27/2015
ZIOPHARM Oncology, Inc. (ZIOP.OB) Reports Fourth-Quarter And Full-Year 2014 Financial Results And Recent Activities 2/27/2015
SAGE Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
Keryx Biopharmaceuticals (KERX) Announces Fourth Quarter And Year-End 2014 Financial Results 2/27/2015
TetraLogic Pharmaceuticals (TLOG) Reports 2014 Financial Results And Provides Clinical Programs Update 2/27/2015
Esperion Therapeutics, Inc. (ESPR) To Provide Fourth Quarter And Full Year ETC-1002 Program Updates And Financial Results 2/27/2015
Biotie Financial Statement Release 2014 2/27/2015
Neovacs SA: Financial Results For 2014 2/27/2015
IGI Laboratories, Inc. To Hold Conference Call For 4th Quarter 2014 Results 2/27/2015
PTC Therapeutics (PTCT) Reports Fourth Quarter And 2014 Full Year Financial Results And Provides Corporate Update 2/27/2015
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For 2014 2/27/2015
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014 2/27/2015
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Fourth Quarter And Year-End 2014 Financial Results On March 12, 2015 2/27/2015
Cerus Corporation (CERS) Reports Fourth Quarter And Year-End 2014 Results 2/27/2015
Concert Pharmaceuticals, Inc. (CNCE) Reports Year End 2014 Financial Results 2/27/2015
Trimel Pharmaceuticals (TRL.TO) To Report Financial Results For 2014 And Host Conference Call To Update Investors 2/27/2015
1st Dental Laboratories (FDT.L) Reports 2014 Fourth Quarter And Full Year Financial Results 2/27/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Year-end Report 2014 2/27/2015
Medivir AB (MVRBF): Financial Statement, January – December 2014 2/27/2015
Nanobiotix 2014 Q4 And Annual Revenues 2/27/2015
Solazyme, Inc. Reports Fourth Quarter And Full Year 2014 Results 2/27/2015
Aegerion (AEGR) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
Ablynx (ABLYF) Announces 2014 Full Year Results 2/26/2015
Histogenics Corporation Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Vical Incorporated (VICL) Reports Fourth Quarter 2014 Financial Results And Progress In Key Development Programs 2/26/2015
Merrimack Pharmaceuticals Inc. (MACK) Reports Fourth Quarter 2014 Financial Results 2/26/2015
NewLink Genetics Provides Operational Update And Reports Fourth Quarter And Year End 2014 Financial Results 2/26/2015
ChemoCentryx, Inc. (CCXI) To Hold Fourth Quarter 2014 Financial Results Conference Call On Thursday, March 12, 2015 2/26/2015
XOMA (US) LLC (XOMA) To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Webcast On March 11 2/26/2015
MedAssets, Inc. To Present At The Barclays Global Healthcare Conference On March 11th 2/26/2015
Cempra Pharmaceuticals, Inc. (CEMP) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/26/2015
Ardelyx Inc. (ARDX) Reports Fourth Quarter and Full Year 2014 Financial Results 2/26/2015
BioMarin (BMRN) Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
China Cord Blood Corporation Reports Financial Results For The Third Quarter And First Nine Months Of Fiscal 2015 2/26/2015
Cellular Dynamics To Host Fourth Quarter And Full Year 2014 Financial Results Webcast And Call 2/26/2015
Radient Technologies Inc. Releases Third Quarter Results And Appoints New Interim CFO 2/26/2015
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For First Quarter Fiscal Year 2015 2/26/2015
CTI BioPharma To Report Fourth Quarter And Full Year 2014 Financial Results On March 12, 2015 2/26/2015
Receptos (RCPT) To Hold Fourth Quarter And Year End 2014 Financial Results Conference Call 2/26/2015
Harvard Bioscience Inc. (HBIO) Fourth Quarter 2014 Non-GAAP EPS Increases 100% Versus Fourth Quarter 2013 On Record Quarterly Revenues Of $30.4 Million 2/26/2015
IMRIS To Hold Fourth Quarter And Annual 2014 Financial Results Conference Call 2/26/2015
ProQR Therapeutics B.V. (PRQR) Announces Results For The Fourth Quarter And Full Year 2014 2/26/2015
RedHill Biopharma Ltd. (RDHL) Reports 2014 Fourth Quarter And Year-End Financial Results 2/26/2015
QLT Inc. (QLTI) Announces Fourth Quarter And Year End 2014 Results 2/26/2015
Akorn, Inc. (AKN) Reports Preliminary Fourth Quarter And Full Year 2014 Results 2/26/2015
Apollo Medical Holdings Reports Third Quarter Fiscal Year 2015 Financial Results 2/26/2015
AxoGen, Inc. (AXGN) To Report Fourth Quarter And Full Year Financial Results On March 5, 2015 2/26/2015
Senomyx, Inc. (SNMX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
SciClone Pharmaceuticals, Inc. (SCLN) To Report Financial Results For The Fourth Quarter And Full Year 2014 On March 11th 2/26/2015
Marina Biotech, Inc. (MRNA) Provides 2014 Year-End Financials And Update 2/26/2015
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 2/26/2015
Geron Corporation (GERN) Announces Conference Call To Discuss Fourth Quarter And Annual 2014 Financial Results And Recent Events 2/26/2015
Dyadic International, Inc. To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2/26/2015
Clovis Oncology (CLVS) Announces 2014 Operating Results 2/26/2015
bluebird bio (BLUE) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Operational Progress 2/26/2015
Anika Therapeutics (ANIK) Reports Fourth-Quarter And Full-Year 2014 Financial Results 2/26/2015
Sarepta (SRPT) Announces Fourth Quarter And Full-Year 2014 Financial Results And Recent Corporate Developments 2/26/2015
Agenus (AGEN) Reports Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Evogene Ltd. (EVGN) Reports Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Medivation, Inc. (MDVN) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/26/2015
Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Year-End 2014 Financial Results On March 5, 2015 2/26/2015
Circassia Pharmaceuticals Plc Preliminary Results For The Year Ended 31 December 2014 2/26/2015
Exelixis, Inc. (EXEL) Announces Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/25/2015
Portola Pharmaceuticals, Inc. To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2 2/25/2015
Curis, Inc. (CRIS) Reports Fourth Quarter And Year-End 2014 Financial Results 2/25/2015
MannKind Corporation (MNKD) Reports 2014 Fourth Quarter And Full Year Financial Results 2/25/2015
Codexis, Inc. (CDXS) To Hold 2014 Fourth Quarter And Full Year Conference Call On March 3 2/25/2015
Amicus Therapeutics, Inc. (FOLD) To Announce Full-Year 2014 Financial Results On March 3, 2015 2/25/2015
Macrocure (MCUR) Announces Fourth Quarter And Full Year 2014 Financial Results Date And Conference Call 2/25/2015
Alder Biopharmaceuticals Inc. To Host Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial And Operating Results 2/25/2015
Parnell Pharmaceuticals Holdings Announces Financial Results For The Six-Month Period Ended December 31, 2014 2/25/2015
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results 2/25/2015
Jazz Pharmaceuticals (JAZZ) Announces Full Year And Fourth Quarter 2014 Financial Results 2/25/2015
Nektar Therapeutics (CA) (NKTR) Reports Fourth Quarter and Year-End 2014 Financial Results 2/25/2015
HEALTHSOUTH Reports Results For Fourth Quarter And Full Year 2014 2/25/2015
Orexigen Therapeutics, Inc. (OREX) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014 2/25/2015
Cipher Pharmaceuticals (DND.TO) Reports Financial Results For Fiscal 2014 2/25/2015
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2014-12-31 2/25/2015
Merck & Co. (MRK) Announces Second-Quarter 2015 Dividend 2/25/2015
Infinity Pharmaceuticals Inc. (INFI) Provides Company Update And Reports Full-Year 2014 Financial Results 2/25/2015
ArQule, Inc. (ARQL) To Report Fiscal 2014 Financial Results On March 4, 2015 2/25/2015
Pernix Therapeutics, Inc. (PTX) Reports Fourth Quarter And 2014 Financial Results And Business Update 2/25/2015
ICON Reports Fourth Quarter And Full Year 2014 Results And Issues 2015 Earnings Guidance 2/25/2015
Foundation Medicine, Inc. (FMI) Announces 2014 Fourth Quarter And Year-End Results, Recent Highlights And 2015 Outlook 2/25/2015
Invitae To Announce Fourth Quarter And Year-End 2014 Financial Results And Host Conference Call On March 10, 2015 2/25/2015
TherapeuticsMD, Inc.  (TXMD) To Host Fourth Quarter, Full-Year 2014 Financial Results Conference Call And Webcast 2/25/2015
Express Scripts Inc. Announces 4th Quarter Results; Provides Initial 2015 Earnings Guidance 2/24/2015
Depomed, Inc. (DEPO) Reports Fourth Quarter And Full Year 2014 Financial Results 2/24/2015
Alimera Sciences (ALIM) To Release Fourth Quarter And Fiscal Year 2014 Financial Results 2/24/2015
PDL BioPharma, Inc. (PDLI) Announces Fourth Quarter And Full Year 2014 Financial Results 2/24/2015
DURECT Corporation (DRRX) Invites You To Join Its Fourth Quarter 2014 Earnings Conference Call 2/24/2015
Halozyme Therapeutics, Inc. (HALO) To Host Fourth Quarter And 2014 Year-End Financial Results Conference Call 2/24/2015
TEI Biosciences Receives Major Contract With Country's Leading Health Care Services Company, Novation, To Bring Biologic Mesh Products To Hundreds Of Thousands Of Patients Nationwide 2/24/2015
IMPAX Labs (IPXL) Revenues Increased 30% To $131 Million In Fourth Quarter 2014 2/24/2015
Cumberland Pharmaceuticals (CPIX) To Announce Fourth Quarter And Annual 2014 Financial Results 2/24/2015
NeoGenomics, Inc. (NGNM.OB) Reports Record Revenue Of $25.0 Million, Adjusted EBITDA Of $2.8 MM And Net Income Of $0.02 Per Share For The Fourth Quarter 2014 2/24/2015
Merge Healthcare (MRGE) Sets Fourth Quarter 2014 Earnings Call 2/24/2015
Endocyte, Inc. (ECYT) Announces Fourth Quarter And Full Year 2014 Earnings Conference Call 2/24/2015
Celldex (CLDX) Reports Fourth Quarter And Year-End 2014 Results 2/24/2015
INC Research, Inc. (INCR) Reports Fourth Quarter And Full-Year 2014 Results 2/24/2015
Ophthotech Corporation (OPHT) Reports Fourth Quarter And Full Year 2014 Financial And Operating Results 2/24/2015
Provectus Biopharmaceuticals Inc. Will Hold Its 2014 Year-End Quarterly Business Update Conference Call At 4 PM Eastern, Thursday, March 12, 2015 2/24/2015
Acceleron Pharma To Host Fourth Quarter And Year Ended 2014 Financial Results Conference Call And Webcast On March 2, 2015 2/24/2015
Dyax Corp. (DYAX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/24/2015
Alkermes plc (ALKS) Reports Financial Results For The Year Ended Dec. 31, 2014 And Provides Financial Expectations For 2015 2/24/2015
EXACT Sciences Corporation (EXAS) Reports Fourth-Quarter And Full-Year 2014 Financial Results 2/24/2015
Pacira Pharmaceuticals, Inc. (PCRX) Reports 2014 Financial Results 2/24/2015
Cleveland Biolabs Inc. (CBLI) Reports Fourth Quarter And Fiscal 2014 Financial Results And Development Progress 2/24/2015
Valeant (VRX) Reports Fourth Quarter And Full Year 2014 Financial Results 2/23/2015
Intrexon Corporation To Announce Fourth Quarter And Full Year 2014 Financial Results On Monday, March 2, 2015 2/23/2015
Arena Pharmaceuticals, Inc. (ARNA) Announces Fourth Quarter And Full Year 2014 Financial Results Conference Call And Webcast On Monday, March 2 2/23/2015
IntelliPharmaCeutics Announces 2014 Year End Results With A 48% Reduction In Operating Loss 2/23/2015
Rockwell Medical (RMTI) Schedules Fourth Quarter Earnings Call 2/23/2015
IntelGenx Corp. Provides Update On Sales Of Forfivo XL 2/23/2015
Intercept Pharmaceuticals (ICPT) To Report Full Year 2014 Financial Results On March 2 And Present At Upcoming Conferences 2/23/2015
Orexigen Therapeutics, Inc. (OREX) To Host Full Year And Fourth Quarter 2014 Financial Results Conference Call And Webcast 2/23/2015
Opexa Therapeutics (OPXA) Reports Year End 2014 Financial Results And Provides Corporate Update 2/23/2015
Eleven Biotherapeutics (EBIO) To Report Fourth Quarter And Full Year 2014 Financial Results On March 4, 2015 2/23/2015
Nordic Nanovector – Fourth Quarter Report 2014 2/23/2015
Nordic Nanovector – Fourth Quarter Report 2014 2/23/2015
Tesaro, Inc. (TSRO) Announces Fourth-Quarter 2014 Operating Results 2/20/2015
Hyperion Therapeutics (HPTX) To Report Fourth Quarter And Full Year 2014 Financial Results After Market On February 26, 2015 2/20/2015
Celldex Therapeutics, Inc. (CLDX) To Report Fourth Quarter And Fiscal 2014 Business/Financial Results And Host 2015 Corporate Strategy Conference Call 2/20/2015
Prothena To Report Fourth Quarter And Full Year 2014 Financial Results And Host Webcast And Conference Call On March 5 2/20/2015
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial Results On February 26, 2015 2/20/2015
Xencor Reports Fourth Quarter And Full Year 2014 Financial Results 2/20/2015
Nuvo Research Inc. (NRI.TO) Announces 2014 Fourth Quarter & Year-End Results 2/20/2015
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' 2014 Financial Results And Highlights Conference Call 2/20/2015



//-->